The adoption of digital health may not be about the speed, nor the idea itself, but rather how well the idea is tailored to suit the unique and complex world of healthcare.
Increasing evidence suggests an interplay between the gut microbiome and nonalcoholic fatty liver disease (NAFLD). The role of the microbiome in the early detection of the condition remains unclear.